Most Recent

image: Addressing Biomedical Science’s PhD Problem

Addressing Biomedical Science’s PhD Problem

By | January 1, 2017

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

7 Comments

image: Staying Active in the Lab

Staying Active in the Lab

By | July 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

8 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Bonding in the Lab

Bonding in the Lab

By | October 1, 2013

How to make your lab less like a factory and more like a family

0 Comments

image: Lab 2.0

Lab 2.0

By | December 1, 2012

Apps and software for improving lab productivity

3 Comments

image: In Times of Trouble

In Times of Trouble

By | August 1, 2012

Scientists share their experiences weathering extremely stressful events without letting their careers get completely derailed.

3 Comments

Scientists who pursue advanced degrees are typically smart. They are driven. And they are no doubt passionate about their work. But can they cut it in industry?

1 Comment

image: The Best of Both Worlds

The Best of Both Worlds

By | April 1, 2012

Choosing to work in industry does not preclude a return to academe. But the move back takes some planning and finesse.

3 Comments

image: Going Governmental

Going Governmental

By | December 1, 2011

Federal agencies offer interesting opportunities for researchers looking to do more than bench work.

12 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham